Grace Therapeutics, Inc. (GRCE) Stock Forecast
Data as of May 10, 2026Healthcare · Current price $2.31 (+2.89%)
Consensus Target
$4.00
Upside
+72.8%
Analysts
1
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
GRCE vs Sector & Market
| Metric | GRCE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 19 |
| Target Upside | +72.8% | +1710.9% | +16.4% |
| P/E Ratio | -5.20 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $7M | $9M | $10M | 1 |
| 2028-03-31 | $37M | $37M | $37M | 2 |
| 2029-03-31 | $100M | $100M | $100M | 1 |
| 2030-03-31 | $118M | $140M | $162M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-03-31 | $-0.77 | $-0.65 | $-0.52 | 1 |
| 2028-03-31 | $0.07 | $0.28 | $0.50 | 2 |
| 2029-03-31 | $1.28 | $1.60 | $1.92 | 1 |
| 2030-03-31 | $1.92 | $2.40 | $2.88 | 1 |
Frequently Asked Questions
What is the analyst consensus for GRCE?
The consensus among 1 analysts covering Grace Therapeutics, Inc. (GRCE) is Buy with an average price target of $4.00.
How many analysts cover GRCE?
1 analysts have issued ratings for Grace Therapeutics, Inc. in the past 12 months.
Is GRCE a buy or sell right now?
Based on 1 analyst ratings, GRCE has a consensus rating of Buy (2.00/5) with a +72.8% upside to the consensus target of $4.00.
What are the earnings estimates for GRCE?
Analysts estimate GRCE will report EPS of $-0.65 for the period ending 2027-03-31, with revenue estimated at $9M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.